Healthcare Global Enterprises Limited Cash Flow Conversion Efficiency
Healthcare Global Enterprises Limited cash flow conversion efficiency. Based on the latest financial reports, Healthcare Global Enterprises Limited (HCG) has a cash flow conversion efficiency ratio of 0.193x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.92 Billion ≈ $20.79 Million USD) by net assets (Rs9.94 Billion ≈ $107.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Healthcare Global Enterprises Limited (2011–2026)
Cash flow conversion efficiency of Healthcare Global Enterprises Limited from 2011 to 2026. This chart illustrates how Healthcare Global Enterprises Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Healthcare Global Enterprises Limited stock price for real-time trading data and today's change.
Healthcare Global Enterprises Limited Cash Flow Conversion Ratio Explained
Healthcare Global Enterprises Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Healthcare Global Enterprises Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Healthcare Global Enterprises Limited ranked by their cash flow conversion efficiency. Also see HCG company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
TAG Colonia-Immobilien AG
HM:KBU
|
N/A |
|
Equital
TA:EQTL
|
0.020x |
|
Zhejiang Garden Bio-chemical High-tech Co Ltd
SHE:300401
|
0.021x |
|
Addnode Group AB (publ)
ST:ANOD-B
|
0.022x |
|
Xiamen Jihong Package Technology Ltd
SHE:002803
|
-0.013x |
|
Hanmi Financial Corporation
NASDAQ:HAFC
|
-0.011x |
|
Innovita Biological Technology Co. Ltd. A
SHG:688253
|
N/A |
|
Rio Tinto PLC
LSE:RIO
|
0.112x |
Annual Cash Flow Conversion Efficiency for Healthcare Global Enterprises Limited (2011–2026)
The table below shows the annual cash flow conversion efficiency of Healthcare Global Enterprises Limited from 2011 to 2026. Review how much free cash does Healthcare Global Enterprises Limited generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs14.10 Billion ≈ $152.51 Million |
Rs3.47 Billion ≈ $37.54 Million |
0.246x | -23.15% |
| 2025-03-31 | Rs9.90 Billion ≈ $107.07 Million |
Rs3.17 Billion ≈ $34.29 Million |
0.320x | -2.63% |
| 2024-03-31 | Rs8.65 Billion ≈ $93.56 Million |
Rs2.85 Billion ≈ $30.78 Million |
0.329x | +13.67% |
| 2023-03-31 | Rs8.69 Billion ≈ $94.02 Million |
Rs2.52 Billion ≈ $27.21 Million |
0.289x | +16.17% |
| 2022-03-31 | Rs8.84 Billion ≈ $95.57 Million |
Rs2.20 Billion ≈ $23.81 Million |
0.249x | +47.57% |
| 2021-03-31 | Rs7.14 Billion ≈ $77.22 Million |
Rs1.21 Billion ≈ $13.03 Million |
0.169x | -45.55% |
| 2020-03-31 | Rs4.20 Billion ≈ $45.40 Million |
Rs1.30 Billion ≈ $14.07 Million |
0.310x | +64.35% |
| 2019-03-31 | Rs5.22 Billion ≈ $56.47 Million |
Rs985.04 Million ≈ $10.65 Million |
0.189x | +11.67% |
| 2018-03-31 | Rs5.79 Billion ≈ $62.62 Million |
Rs978.13 Million ≈ $10.58 Million |
0.169x | -9.29% |
| 2017-03-31 | Rs4.90 Billion ≈ $53.00 Million |
Rs912.79 Million ≈ $9.87 Million |
0.186x | +16.66% |
| 2016-03-31 | Rs4.59 Billion ≈ $49.59 Million |
Rs731.97 Million ≈ $7.92 Million |
0.160x | -44.47% |
| 2015-03-31 | Rs2.08 Billion ≈ $22.44 Million |
Rs596.53 Million ≈ $6.45 Million |
0.287x | +57.70% |
| 2014-03-31 | Rs2.82 Billion ≈ $30.51 Million |
Rs514.22 Million ≈ $5.56 Million |
0.182x | +73.35% |
| 2013-03-31 | Rs2.96 Billion ≈ $32.01 Million |
Rs311.26 Million ≈ $3.37 Million |
0.105x | +4206.51% |
| 2012-03-31 | Rs2.19 Billion ≈ $23.73 Million |
Rs-5.62 Million ≈ $-60.78K |
-0.003x | -102.04% |
| 2011-03-31 | Rs1.76 Billion ≈ $19.08 Million |
Rs221.98 Million ≈ $2.40 Million |
0.126x | -- |
About Healthcare Global Enterprises Limited
HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncol… Read more